Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Mac who wrote (154)	6/29/1998 4:55:00 PM
From: Andrew Abrams	Read Replies (1) \| Respond to of 413

He was also the hi estimate on the street and has now come into line with everyone else. He based his change (as many analysts do) on incorrect information concerning the renegotiation of a large contract with a surgeon (justification). After conversation with the company today, it turns out that this was not the case and they see no additional price pressure from any source. (as they stated on the conference call). It was all a waste of time and energy. good luck.

To: Jim Mac who wrote (154)	6/29/1998 8:45:00 PM
From: Jim Mac	Read Replies (1) \| Respond to of 413

Sorry. I meant to say "3,600 in May". Since LVCI's U.S. procedure count is growing more rapidly than international, and U.S. is now 89% of all LVCI procedures, this bodes well for LVCI's cash flow going forward. That analyst could indeed be very wrong, as analysts were with Visx. Since May procedure count was 3,600 and average monthly count for April Q was 3,300, and 89% of procedures now U.S., it looks like June could be up to 3,900, and July 4,200 roughly speaking, and especially since a couple dozen contracts began since Jan 1, which are still young. So, maybe July Q procedures will be up 18% over April Q, to 11,700+/-, making EPS $0.10. Any comments, anyone?